Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtre
Ajouter des filtres








Gamme d'année
1.
Indian J Exp Biol ; 2015 Feb; 53(2): 67-74
Article Dans Anglais | IMSEAR | ID: sea-158377

Résumé

The catabolism of fungal 4-aminobutyrate (GABA) occurs via succinic semialdehyde (SSA). Succinic semialdehyde dehydrogenase (SSADH) from the acidogenic fungus Aspergillus niger was purified from GABA grown mycelia to the highest specific activity of 277 nmol min-1 mg-1, using phenyl Sepharose and DEAE Sephacel chromatography. The purified enzyme was specific for its substrates SSA and NAD+. The substrate inhibition observed with SSA was uncompetitive with respect to NAD+. While product inhibition by succinate was not observed, NADH inhibited the enzyme competitively with respect to NAD+ and noncompetitively with respect to SSA. Dead-end inhibition by AMP and p-hydroxybenzaldehyde (pHB) was analyzed. The pHB inhibition was competitive with SSA and uncompetitive with NAD+; AMP competed with NAD+. Consistent with the kinetic data, a sequential, ordered Bi Bi mechanism is proposed for this enzyme.


Sujets)
AMP/métabolisme , AMP/pharmacologie , Aspergillus niger/enzymologie , Aspergillus niger/métabolisme , Benzaldéhydes/métabolisme , Benzaldéhydes/pharmacologie , Fixation compétitive , Biocatalyse/effets des médicaments et des substances chimiques , Protéines fongiques/isolement et purification , Protéines fongiques/métabolisme , Cinétique , Mycelium/enzymologie , Mycelium/métabolisme , NAD/métabolisme , NAD/pharmacologie , Liaison aux protéines , Spécificité du substrat , Succinate-semialdehyde dehydrogenase/isolement et purification , Succinate-semialdehyde dehydrogenase/métabolisme , Acide gamma-amino-butyrique/analogues et dérivés , Acide gamma-amino-butyrique/métabolisme , Acide gamma-amino-butyrique/pharmacologie
2.
Indian J Physiol Pharmacol ; 2001 Jul; 45(3): 367-72
Article Dans Anglais | IMSEAR | ID: sea-108791

Résumé

Monoclonal antibodies (MAb) constitute the centre of all in-vitro diagnostic measures and almost all in-vivo therapeutic manoeuvres now. Production emphasis for these antibodies is having a current shift from animal-based large-scale culture to in-vitro bioreactor-based high-density culture. One of the major difficulties in high-density culture is end-metabolite accumulation in batch and fed-batch cultures in the forms of H+, NH4+ etc.. thereby reducing cellular growth and secretions. In the present study, effects of added proton carries--NAD and NADP--over and above the metabolic pools of the molecules, were examined on the cellular growth and secretion kinetics. Although NADP fortification showed a remarkable improvement in cellular growth (time dependent 200-300% improvements compared to controls) and size, cumulative MAb titre was better with NAD fortification. Combined additional loads of the proton carriers would be interesting to study in high density culture conditions.


Sujets)
Algorithmes , Animaux , Division cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire , Chromatographie en phase liquide à haute performance , Milieux de culture , Électrophorèse sur gel de polyacrylamide , Test ELISA , Hybridomes/effets des médicaments et des substances chimiques , Lysine/pharmacologie , Souris , Muromonab-CD3/biosynthèse , NAD/pharmacologie , Protons , Spectrophotométrie UV , Activation chimique
3.
Indian J Biochem Biophys ; 1991 Oct-Dec; 28(5-6): 389-94
Article Dans Anglais | IMSEAR | ID: sea-28668

Résumé

Candida 107 (NCYC 911) accumulates up to 45% of the biomass as triglycerides under conditions of nitrogenous substrate limitation in the medium. In oilseeds and adipocytes, lipid accumulation is preceded and accompanied by increased activity of key enzymes such as pyruvate dehydrogenase. However, in Candida 107, the activity of this complex was greatly reduced during lipogenesis. The initial velocity patterns were in accordance with a Hexa Uni Ping Pong mechanism. The Km values for the various substrates were similar to those found for the yeast Saccharomyces cerevisiae, but much higher than those reported for the mammalian enzyme. Product inhibition studies indicated that the Ki for acetyl coenzyme A and NADH were higher than those reported for other yeasts. The values for Ki were similar to those found for the liver enzyme, whereas the enzyme complex from heart had much lower Ki values for products. It has been suggested that in the heart and kidney, pyruvate dehydrogenase is regulated by product inhibition whereas in the liver this does not appear to be the mechanism. Therefore, it is probable, that like the liver enzyme, pyruvate dehydrogenase from Candida 107 may not be regulated by product inhibition.


Sujets)
Acétyl coenzyme A/pharmacologie , Candida/métabolisme , Cinétique , Métabolisme lipidique , NAD/pharmacologie , Complexe du pyruvate déshydrogénase/antagonistes et inhibiteurs
SÉLECTION CITATIONS
Détails de la recherche